36
Views
15
CrossRef citations to date
0
Altmetric
Article

Is the risk of hypertension an indication for prophylactic nephrectomy in patients with unilateral multicystic dysplastic kidney?

, , , &
Pages 429-432 | Received 23 Sep 2002, Accepted 12 Mar 2003, Published online: 09 Jul 2009
 

Abstract

Objective: Surgery is still proposed by some as the treatment of choice for unilateral multicystic dysplastic kidney (UMCDK) because of the potential complications of hypertension, infection and malignant change. The purpose of this study is to demonstrate that the risk of hypertension does not justify routine nephrectomy.

Material and Methods: We report 41 cases of UMCDK, treated between 1980 and 2001, 28 of whom were male (68%). Twenty‐one patients were nephrectomized (51%). Twenty patients (49%) underwent clinical and ultrasound follow‐up. Blood pressure was controlled every 3–4 months (over a period ranging from 9 months to 6 years) and an ultrasound scan was performed every 6 months during the first 2 years, and annually thereafter.

Results: In the patients treated non‐operatively we observed a progressive spontaneous involution of their multicystic dysplastic kidneys and the total absence of complications such as hypertension or malignancy.

Conclusion: It is reasonable to conservatively manage patients with UMCDK by means of repeated ultrasound examinations and blood pressure control.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.